Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Sales | 15,788 | 10,346 | 15,624 | 19,258 | 18,219 |
| Cost of Goods | N/A | 430 | 3,054 | 2,810 | 1,852 |
| Gross Profit | 15,788 | 9,916 | 12,570 | 16,448 | 16,367 |
| Operating Expenses | 49,437 | 43,832 | 40,881 | 41,507 | 38,882 |
| Operating Income | -33,649 | -33,486 | -28,257 | -24,249 | -21,663 |
| Interest Expense | 3,011 | 3,010 | 3,011 | 3,011 | 3,011 |
| Other Income | 6,743 | 5,525 | 3,858 | 3,684 | 3,481 |
| Pre-tax Income | -29,917 | -30,971 | -27,410 | -23,576 | -21,193 |
| Net Income Continuous | -29,917 | -30,971 | -27,410 | -23,576 | -21,193 |
| Net Income | $-29,917 | $-30,971 | $-27,410 | $-23,576 | $-20,380 |
| EPS Basic Total Ops | -0.46 | -0.52 | -0.48 | -0.41 | -0.36 |
| EPS Basic Continuous Ops | -0.46 | -0.52 | -0.48 | -0.41 | -0.37 |
| EPS Diluted Total Ops | -0.46 | -0.52 | -0.48 | -0.41 | -0.36 |
| EPS Diluted Continuous Ops | -0.46 | -0.52 | -0.48 | -0.41 | -0.37 |
| EBITDA(a) | $-30,794 | $-30,090 | $-24,549 | $-20,559 | $-17,865 |